Detalhe da pesquisa
1.
Impact of asthma on bronchiectasis severity and risk of exacerbations.
J Asthma
; 59(3): 469-475, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256490
2.
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.
Respir Med
; 185: 106491, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098492
3.
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study.
J Asthma Allergy
; 14: 1441-1452, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34880630
4.
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
Eur Respir Rev
; 30(160)2021 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039675
5.
Comparability of asthma control test scores between self and physician-administered test.
Respir Med
; 170: 106015, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843163
6.
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.
World Allergy Organ J
; 13(9): 100462, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32994855